Major depressive disorder (MDD) is a debilitating disorder and its pathophysiology is associated with deregulation of the immune system. We investigated the changes in circulating levels of proinflammatory cytokines (specifically IL-6 and TNF-α) measured by the ELISA kit in two psychotherapeutic interventions for MDD: Narrative Cognitive Therapy (NCT) and Cognitive Behavioral Therapy (CBT). This is a randomized clinical trial including 97 individuals (18 to 29 years-old) with MDD. In CBT there was a significant difference in serum levels of IL-6 and TNF-α, therefore indicating that CBT was more effective than NCT on serum levels proinflammatory cytokines.
Introduction
Major depressive disorder (MDD) is a debilitating disorder with a lifetime prevalence ranging from 10% to 15% (Luca et al., 2013) . The pathogenesis of this disorder is not completely understood, however studies have suggested that deregulation of the immune system, particularly the inflammatory cytokines, is associated with the physiopathology of depression (Blume et al., 2011; Dowlati et al., 2010) .
Cytokines are polypeptides with immunoregulating and modulating functions of the neural system (Wang et al., 2002) . Proinflammatory cytokines, such as the Interleukin-6 (IL-6) and the Tumor Necrosis Factor alpha (TNF-α), play important roles in the central nervous system, including synaptogenesis and neuronal plasticity (Kim et al., 2013; Maes et al., 2012) . Studies have suggested that depressed patients show increased levels of proinflammatory cytokines (Munzer et al., 2013; Schiepers et al., 2005) . Furthermore, this increase seems to be correlated to the severity of this psychiatric disorder (Maes et al., 2012; Schiepers et al., 2005) .
Pharmacological treatments act on modulating cytokine production, decreasing its levels (Hannestad et al., 2011; Munzer et al., 2013) . However, little is known about the effect of psychotherapy in reducing these levels. Cognitive Behavioral Therapy (CBT) has been effective in improving depressive symptoms (Butler et al., 2006) , but few studies have showed changes in inflammatory parameters after nonpharmacological interventions (e.g., hypnosis, relaxation, mindfulnessbased and cognitive-behavioral training) (Keri et al., 2014) . The aim of this study was to determine whether psychotherapeutic interventions for MDD are associated with changes in circulating levels of inflammatory cytokines, specifically IL-6 and TNF-α.
Methods

Design
This is a randomized clinical trial that assesses the effectiveness of brief psychotherapy models in the regulation of pro-inflammatory markers in remission of the depressive symptoms. A convenience sample was recruited through advertisements at Community Health Centers and local media.
The participants were informed about the research objectives and signed a "Term of Free and Informed Consent". In this research protocol, all ethical procedures established by the National Health Council, Resolution number 196, October of 1996, were followed. The project was approved by the ethical committee of the university, protocol number 2009/24.
Interventions
The handbook of Cognitive Behavioral Therapy (CBT) was structured in agreement with Aaron Beck's theory (Beck, 1997) . This model of psychotherapy proposes that the distorted or dysfunctional thinking which influences mood and behavior is common to all psychological disorders. An accurate assessment and modification in thinking lead to improvements in mood and behavior. Lasting improvements result from the modification of the basic dysfunctional beliefs.
The Handbook of Narrative Cognitive Therapy (NCT) was established according to the proposition of Oscar Gonçalves (1998) , from the University of Minho (Portugal) (Gonçalves, 1998) . This model aims to reframe personal narratives by elaborating a new biography based on life stories that lost meaning and became incoherent. The new narratives and interpretations are integrated into the personal stories in a coherent and meaningful way.
Both interventions were performed for seven weekly sessions (one session a week) with one hour of duration, at the Hospital Universitário São Francisco de Paula (HUSFP). The sessions were conducted by undergraduate students in the last year of Psychology from the Universidade Católica de Pelotas (UCPel). All students received two months of training and were weekly supervised by senior psychologists.
Data collection
Participants were evaluated regarding sociodemographic data (gender, age, and years of education). Economic status was measured using the National Economic Index (NEI), an instrument that was developed using as main component the analysis that considered the Brazilian census of 2000 as a parameter. The instrument is based on the individual's material assets and the education level of the head of the household (Barros and Victora, 2005) .
Outcome measures
The Hamilton Depression Rating Scale (HDRS) (Hamilton, 1967) was used to measure the severity of depressive symptoms at baseline and post-intervention.
Biochemical analyses
For the biochemical analyses, 10 mL of blood were withdrawn from each subject by venipuncture into an anticoagulant-free vacuum tube at baseline and post-intervention. All venous blood samples were taken in the morning (between 9:00 and 11:00 am). The blood was immediately centrifuged at 4000 ×g for 10 min, and serum was kept frozen at − 80°C until analysis. Serum IL-6 and TNF-α levels were measured using a commercial immunoassay kit (DuoSet ELISA Development, R&D Systems, Inc., USA). Serum IL-6 and TNF-α levels were expressed in pg/mL.
Randomization
The randomization was performed by a person who was not involved in the evaluation process or the therapeutic intervention; this same person raffled papers from a brown envelope with the indication of the therapy model. Subjects who met the inclusion criteria were randomized between the two models of brief interventions: NCT and CBT.
Blinding
The researchers who were responsible for baseline and postintervention assessments and the participants were blinded regarding the intervention model.
Statistical analysis
Statistical analysis was conducted in the SPSS 21.0 software. Chisquare and t tests were used to assess data homogeneity between the intervention models at baseline. Serum IL-6 and TNF-α levels had non-Gaussian distributions. For nonparametric data, we used Wilcoxon test. Serum cytokines levels were presented using median and interquartile range. Results with p value ≤ 0.05 were considered statistically significant.
Results
We initially assessed 282 subjects. From these, a total of 162 subjects did not meet the inclusion criteria, which resulted in 120 participants (60 NCT and 60 CBT); 23 subjects (NCT = 9 and CBT = 14) were excluded from our sample after scheduling the first session and not attending it for three times. We analyzed data from 97 participants (51 NCT and 46 CBT) at baseline.
During the intervention period, 23 participants (NCT = 12 and CBT = 11) dropped out from the treatment reporting lack of time as the main reason. The participants who presented suicide risk throughout the intervention (NCT = 1 and CBT = 5) were excluded from the study. They received psychological treatment and medication, and their family was informed about the suicide risk. Therefore, 68 participants (NCT = 38 and CBT = 30) completed the therapy and participated in the final assessment. Nevertheless, two blood samples from the CBT model could not be included in the analysis due to hemolyzation.
There was no significant difference between sociodemographic variables and the therapy models. The average age was 23.89 ± 3.18 and 24.46 ± 3.61 in NCT and CBT, respectively. Also, 81.6% of the NCT participants and 75% of the CBT participants are female. Moreover, there was no difference in the severity of depressive symptoms between therapy models (Table 1) .
Severity of depressive symptoms was significantly different from baseline to post-intervention (p b 0.001) in NCT, whereas there was no significant difference in the serum levels of IL-6 (p = 0.987) and TNF-α (p = 0.651) in this same intervention (Table 1) . Regarding the CBT intervention, there was a significant difference on the severity of depressive symptoms (p b 0.001), as well as in the serum levels of IL-6 (p = 0.042) and TNF-α (p = 0.050) ( Table 2 ; Fig. 1 ). In addition, CBT was more effective than NCT regarding the remission of depressive symptoms (p = 0.018). There was no significant correlation between the remission of depressive symptoms and the changes in the serum levels of IL-6 (r = 0.018; p = 0.933) and TNF-α (r = 0.067; p = 0.734) in the CBT, nor in the serum levels of IL-6 (r = 0.071; p = 0.679) and TNF-α (r = −0.026; p = 0.882) in the NCT.
Discussion
This randomized clinical trial evaluated the impact of two brief cognitive therapy models for depression, CBT and NCT, on the serum levels of proinflammatory cytokines (IL-6 and TNF-α). Depressive symptoms were significantly reduced at post-intervention on both intervention models, and the CBT was more effective than NCT regarding the remission of these symptoms. Therefore, the serum levels of IL-6 and TNF-α significantly decreased only in the patients treated with CBT.
Depression has been associated with increased proinflammatory cytokines levels, including IL-6 and TNF-α, which indicates a role of inflammatory processes on the physiopathology of depression (Maes et al., 2012; Miller et al., 2009; Schiepers et al., 2005) . One metanalysis of Dowlati et al. (2010) demonstrated that the only proinflammatory markers that are significantly increased in depressed patients are the IL-6 and TNF-α, as compared to healthy controls. Even though the aim of this study was not to compare depressed patients with a control group, we have identified increased serum levels of IL-6 and TNF-α at baseline as compared to post-intervention. This corroborates the existing relationship between depression and cytokines (Dantzer et al., 2008; Haddad et al., 2002; Tian et al., 2014) , in which the increase of these cytokines may be related to a hyperactivity of the hypothalamus-pituitary-adrenal (HPA) axis, which is the main component of the endocrinal system of stress response and an important well-known ethiological factor of depression. A recent metanalysis showed that psychological stress was associated with an acute inflammatory response, with an increase in the levels of IL-6, IL-1β, TNF-α and C-reactive protein (CPR) (Steptoe et al., 2007) . The activation of the HPA axis, with resulting increase in the levels of cortisol, and its association with depression has been documented in several studies (Burke et al., 2005; Cubala and Landowski, 2014; Matsuzaka et al., 2013) .
There is evidence that medication treatment has specific effects on inflammatory response, and it is able to decrease the IL-6 levels in depressed patients (Kubera et al., 2000; Maes et al., 2012; Schiepers et al., 2005) . One metanalysis of clinical trials verified the impact of antidepressant medication on three inflammatory markers (IL-6, CPR and IL-10), and observed a significant decrease in the IL-6 and CPR levels after treatment, whereas there was no significant decrease in the IL-10 Table 2 Median and interquartile interval of severity of depressive symptoms and serum IL-6 and TNF-α levels at baseline and post-intervention. Legend: HDRS = Hamilton Depression Rating Scale; IL-6 = interleukin-6; TNF-α = tumor necrosis factor. ⁎ Analysis by Wilcoxon. levels (Hannestad et al., 2011) . In the same way, Lanquillon et al. (2000) observed a decrease in the TNF-α levels after pharmacological treatment.
Studies that evaluate the impact of psychotherapeutic interventions on depressive symptoms and on inflammatory markers are very important, since they may play a fundamental role both on the prevention of relapses and on the stability of the inflammatory markers. It is important to highlight that the increase of inflammatory markers may influence neural plasticity and result in new episodes of depression throughout time (Khairova et al., 2009 ). Thus, psychotherapy models that act on the remission of symptoms and neurobiological systems changes, may be effective regarding the maintenance of symptom remission and the prevention of new depressive episodes at long-term.
Some studies have demonstrated that CBT may be as effective as psychopharmacological intervention for mood disorders, particularly in the treatment of depression (DeRubeis et al., 2005) . Hollon et al. (2005) compared the effectiveness of CBT and antidepressive medication in depressed patients for 16 weeks, and they observed that the patients who had been treated with CBT were less prone to relapses, when compared to the other patients. One study that compared the NCT and the CBT in the treatment of moderate depression verified that the CBT was more effective than NCT in the improvement of depressive symptoms (Lopes et al., 2014) . The present study also revealed a superiority of CBT in relation to NCT concerning the remission of depressive symptoms. This may be the main reason why we verified a significant decrease in the serum levels of IL-6 and TNF-α only in CBT. One study with individuals presenting insomnia without psychiatric disorders observed a decrease in the inflammatory cytokine levels after CBT, although this decrease was not significant (Chen et al., 2008) . The present study is among the first ones to evaluate proinflammatory cytokine levels after brief cognitive therapy, which demonstrates that CBT is effective in the treatment of depressive symptoms, and it also decreases the concentrations of TNF-α and IL-6 in a sample of young adults.
This study verified the effectiveness of a brief intervention in a population of young adults, who are possibly in the first mood episode or have had a low number of recurrences. The results indicated an improvement of the depressive symptoms and a decrease in the proinflammatory cytokines serum levels at post-intervention. Therefore, these findings are limited regarding their generalization to other populations. Studies with other populations that evaluate the longterm results of psychotherapy on cytokine serum levels, are important to verify the maintenance of symptom improvement and prevention of relapses.
